Article

Rite Aid Sees Advantage in Buying an Established PBM

The New York Times reported today that the drug store chain Rite Aid will buy Envision Pharmaceutical Services, a pharmacy benefit manager, for $2 billion.

Rite Aid, the big pharmacy chain, agreed on Wednesday to acquire a top pharmacy benefit manager, Envision Pharmaceutical Services, for $2 billion in cash and stock .

Envision Pharmaceutical Services, known as EnvisionRx, is owned by the private equity firm TPG, making this one of the year’s early successful exits for a buyout firm.

Rite Aid will pay TPG about $1.8 billion in cash and $200 million in stock for EnvisionRx. The value of the deal also includes an expected future tax benefit of $275 million.

Complete report on The New York Times:

http://nyti.ms/1A0g8TS

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Sundar Jagannath
Dr Muhammad Faizan
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
Hadar Avihai Lev-Tov, MD
4 experts in this video
4 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo